Fulgent Genetics (NASDAQ:FLGT – Get Free Report) and EUDA Health (NASDAQ:EUDA – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, dividends and analyst recommendations.
Analyst Recommendations
This is a summary of current recommendations for Fulgent Genetics and EUDA Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Fulgent Genetics | 1 | 2 | 2 | 0 | 2.20 |
| EUDA Health | 1 | 1 | 1 | 0 | 2.00 |
Fulgent Genetics presently has a consensus price target of $27.00, indicating a potential upside of 33.93%. EUDA Health has a consensus price target of $55.00, indicating a potential upside of 361.60%. Given EUDA Health’s higher possible upside, analysts plainly believe EUDA Health is more favorable than Fulgent Genetics.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Fulgent Genetics | -23.04% | -3.24% | -2.97% |
| EUDA Health | N/A | N/A | N/A |
Volatility & Risk
Fulgent Genetics has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, EUDA Health has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500.
Earnings and Valuation
This table compares Fulgent Genetics and EUDA Health”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Fulgent Genetics | $322.67 million | 1.77 | -$60.51 million | ($2.39) | -8.44 |
| EUDA Health | $6.82 million | 5.22 | -$2.77 million | N/A | N/A |
EUDA Health has lower revenue, but higher earnings than Fulgent Genetics.
Insider and Institutional Ownership
48.1% of Fulgent Genetics shares are owned by institutional investors. Comparatively, 4.3% of EUDA Health shares are owned by institutional investors. 36.2% of Fulgent Genetics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
About Fulgent Genetics
Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company’s clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.
About EUDA Health
EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.
Receive News & Ratings for Fulgent Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fulgent Genetics and related companies with MarketBeat.com's FREE daily email newsletter.
